PL142759B1 - Process for preparing derivatives of hydantoin - Google Patents

Process for preparing derivatives of hydantoin Download PDF

Info

Publication number
PL142759B1
PL142759B1 PL1984247379A PL24737984A PL142759B1 PL 142759 B1 PL142759 B1 PL 142759B1 PL 1984247379 A PL1984247379 A PL 1984247379A PL 24737984 A PL24737984 A PL 24737984A PL 142759 B1 PL142759 B1 PL 142759B1
Authority
PL
Poland
Prior art keywords
product
compounds
dione
spiro
fluoro
Prior art date
Application number
PL1984247379A
Other languages
English (en)
Polish (pl)
Other versions
PL247379A1 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL247379A1 publication Critical patent/PL247379A1/xx
Publication of PL142759B1 publication Critical patent/PL142759B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/96—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL1984247379A 1983-04-27 1984-04-24 Process for preparing derivatives of hydantoin PL142759B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/488,947 US4474967A (en) 1983-04-27 1983-04-27 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione

Publications (2)

Publication Number Publication Date
PL247379A1 PL247379A1 (en) 1985-03-26
PL142759B1 true PL142759B1 (en) 1987-11-30

Family

ID=23941785

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1984247379A PL142759B1 (en) 1983-04-27 1984-04-24 Process for preparing derivatives of hydantoin

Country Status (22)

Country Link
US (1) US4474967A (OSRAM)
EP (1) EP0124327A3 (OSRAM)
JP (1) JPS59205384A (OSRAM)
KR (1) KR860000915B1 (OSRAM)
AU (1) AU542142B2 (OSRAM)
CA (1) CA1226866A (OSRAM)
CS (1) CS250661B2 (OSRAM)
DD (1) DD219772A5 (OSRAM)
DK (1) DK208284A (OSRAM)
ES (1) ES8607312A1 (OSRAM)
FI (1) FI841657A7 (OSRAM)
GR (1) GR81491B (OSRAM)
HU (1) HU191755B (OSRAM)
IL (1) IL71656A (OSRAM)
NO (1) NO841627L (OSRAM)
NZ (1) NZ207959A (OSRAM)
PH (1) PH22869A (OSRAM)
PL (1) PL142759B1 (OSRAM)
PT (1) PT78476B (OSRAM)
SU (1) SU1240362A3 (OSRAM)
YU (1) YU43358B (OSRAM)
ZA (1) ZA843091B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3565105D1 (en) * 1984-08-20 1988-10-27 Pfizer Process for the production as asymmetric hydantoins
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
GB9317764D0 (en) * 1993-08-26 1993-10-13 Pfizer Ltd Therapeutic compound
KR20010040457A (ko) * 1998-01-30 2001-05-15 우에노 류지 안약 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation

Also Published As

Publication number Publication date
FI841657L (fi) 1984-10-28
GR81491B (OSRAM) 1984-12-11
IL71656A (en) 1987-10-20
HU191755B (en) 1987-04-28
YU74184A (en) 1986-10-31
US4474967A (en) 1984-10-02
ZA843091B (en) 1985-12-24
JPS59205384A (ja) 1984-11-20
DK208284D0 (da) 1984-04-26
PT78476B (en) 1986-08-28
NZ207959A (en) 1987-04-30
PT78476A (en) 1984-05-01
SU1240362A3 (ru) 1986-06-23
CS250661B2 (en) 1987-05-14
ES8607312A1 (es) 1986-06-01
KR840008355A (ko) 1984-12-14
DD219772A5 (de) 1985-03-13
NO841627L (no) 1984-10-29
HUT34197A (en) 1985-02-28
DK208284A (da) 1984-10-28
AU542142B2 (en) 1985-02-07
KR860000915B1 (ko) 1986-07-18
CA1226866A (en) 1987-09-15
FI841657A7 (fi) 1984-10-28
YU43358B (en) 1989-06-30
FI841657A0 (fi) 1984-04-26
PL247379A1 (en) 1985-03-26
ES531873A0 (es) 1986-06-01
IL71656A0 (en) 1984-07-31
EP0124327A2 (en) 1984-11-07
EP0124327A3 (en) 1985-07-31
AU2726384A (en) 1984-11-01
PH22869A (en) 1989-01-19

Similar Documents

Publication Publication Date Title
De Sarro et al. 5H-[1, 2, 4] Oxadiazolo [5, 4-d][1, 5] benzothiazepines as anticonvulsant agents in DBA/2 mice
CN102295642B (zh) 2-芳基咪唑并[1,2-a]吡啶-3-乙酰胺衍生物、其制备方法及用途
US8389544B2 (en) Isoquinolone compounds as subtype-selective agonists for melatonin receptors MT1 and MT2
WO2016166546A1 (en) An antimicrobial compound
WO2024008129A1 (zh) 作为kat6抑制剂的化合物
AU2016302755A1 (en) 5-HT2C receptor agonists and compositions and methods of use
Kupchan et al. Tumor inhibitors. 89. Structural requirements for tumor-inhibitory activity among benzylisoquinoline alkaloids and related synthetic compounds
GB2194236A (en) 1-(4-aminophenyl)-4-methyl-7, 8-methylenedioxy-3, 4-dihydro-5h-2, 3-benzodiazepine acid addition salts thereof and process for preparing same
US5476933A (en) Azepine synthesis via a diels-alder reaction
US6034246A (en) 2-arylbenzazole compounds
US4490381A (en) 1'-Substituted spiro[imidazolidine-4,3'-indoline]2,2',5-triones
SK165795A3 (en) 3-phenylizoquinoline-1(2h)-one derivatives, preparation method and pharmaceutical compounds containing these derivatives
JPH04234860A (ja) チアジン（又はオキサジン）誘導体、その製法及びその合成中間体
Hajlaoui et al. Design, Synthesis and biological evaluation of novel benzopyran derivatives as potential α-amylase inhibitors: An Investigation by Experimental and Computational Studies
PL142759B1 (en) Process for preparing derivatives of hydantoin
CA2792918C (en) Benzazepine compound
EP0269755A1 (en) DIBENZ b,e OXEPIN DERIVATIVE AND PHARMACEUTICAL CONTAINING THE SAME AS ACTIVE INGREDIENT
EA020010B1 (ru) БИЦИКЛИЧЕСКИЕ ТИАЗОЛЫ В КАЧЕСТВЕ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ mGluR5 РЕЦЕПТОРОВ
SU1170971A3 (ru) Способ получени производных бензодиазепина или их сол нокислых солей
Bertha et al. (E)-8-Benzylidene Derivatives of 2-Methyl-5-(3-hydroxyphenyl) morphans: Highly Selective Ligands for the. sigma. 2 Receptor Subtype
Watthey et al. Synthesis and biological properties of thiophene ring analogs of mianserin
US6020364A (en) Compounds and method of treating psychosis and schizophrenia
Robbins et al. (Aminoalkyl) carbamates of forskolin: intermediates for the synthesis of functionalized derivatives of forskolin with different specificities for adenylyl cyclase and the glucose transporter
EP4610256A1 (en) Piperidinopyrimidine derivative, preparation method therefor and use thereof in medicine
IE883136L (en) Ó(2)-adreno receptor antagonists